& Hellstrm, M
Therefore, increased monitoring of valproate and concomitant drug concentrations and dosage adjustment are indicated whenever enzyme-inducing or inhibiting drugs are introduced or withdrawn (7.1) Aspirin, carbapenem antibiotics, estrogen-containing hormonal contraceptives, methotrexate: Monitoring of valproate concentrations is recommended (7.1) Co-administration of valproate can affect the pharmacokinetics of other drugs (e.g., diazepam, ethosuximide, lamotrigine, phenytoin) by inhibiting their metabolism or protein binding displacement (7.2) Patients stabilized on rufinamide should begin valproate therapy at a low dose, and titrate to clinically effective dose (7.2) Dosage adjustment of amitriptyline/nortriptyline, propofol, warfarin, and zidovudine may be necessary if used concomitantly with divalproex sodium extended-release tablets (7.2) Topiramate: Hyperammonemia and encephalopathy (5.10, 7.3) Cannabidiol: ALT and/or AST elevation (7.4) Use In Specific Populations Pregnancy: Divalproex sodium extended-release tablets can cause congenital malformations including neural tube defects, decreased IQ, and neurodevelopmental disorders
The run was performed in ESI positive ion mode, and the mobile phases were A: water, 0.5% formic acid, 1 mM ammonium formate, and B: 90:10 ACN/Water (v/v), 0.5% formic acid, 1 mM ammonium formate
Consistent intake is often recommended because glutathione works gradually to support antioxidant defense, skin health, and overall wellness
ABCC1 levels dictate the response of AML to Venetoclax Expression analysis of ABC transporters in AML patients in the BeatAML dataset 47 showed that unlike AML cell lines (Supplementary Fig
